Combined Nasal Administration of Encephalitogenic Myelin Basic Protein Peptide 68–86 and IL-10 Suppressed Incipient Experimental Allergic Encephalomyelitis in Lewis Rats
- 30 September 2000
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 96 (3) , 205-211
- https://doi.org/10.1006/clim.2000.4895
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of T‐cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T‐cell‐dependent functionsImmunology, 1999
- Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNAJournal of Neuroimmunology, 1997
- Altered Immune Responses in Interleukin 10 Transgenic MiceThe Journal of Experimental Medicine, 1997
- The Oral Administration of Low-Dose Antigen Induces Activation Followed by Tolerization, While High-Dose Antigen Induces Tolerance without ActivationClinical Immunology and Immunopathology, 1997
- Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivoInternational Immunology, 1996
- Limited capacity for tolerization of CD4+ T cells specific for a pancreatic β cell neo-antigenImmunity, 1995
- Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivoImmunity, 1994
- Interleukin‐10 prevents experimental allergic encephalomyelitis in ratsEuropean Journal of Immunology, 1994
- Determinant spreading and the dynamics of the autoimmune T-cell repertoireImmunology Today, 1993
- Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.The Journal of Experimental Medicine, 1990